What is the ticker symbol for Sarepta Therapeutics?

Sarepta Therapeutics trades under the ticker SRPT on NASDAQ.

What sector does Sarepta Therapeutics operate in?

Sarepta Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze SRPT in a portfolio?

PortView shows SRPT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Sarepta Therapeutics (SRPT) Stock Analysis

NASDAQHealthcareBiotechnology

$22.08+3.52%

1-year price historyRange $14.86 – $24.45

52-week range$22.08

$14.68$25.32

What Sarepta Therapeutics does

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company dedicated to the discovery and advancement of genetic treatment modalities, including RNA-targeted therapeutics and gene therapies, specifically for rare diseases. The company currently offers two approved treatments: EXONDYS 51, prescribed for Duchenne muscular dystrophy (DMD) patients with confirmed dystrophin gene mutations amenable to exon 51 skipping, and VYONDYS 53, for DMD patients with exon 53 skipping mutations. Sarepta's development pipeline includes AMONDYS 45, an exon-skipping product candidate utilizing phosphorodiamidate morpholino oligomer chemistry for exon 45; SRP-5051, a peptide-conjugated PMO designed to target exon 51 of dystrophin pre-mRNA; and gene therapy programs such as SRP-9001 for DMD and SRP-9003 for limb-girdle muscular dystrophies. The company maintains collaborative agreements with organizations like F. Hoffman-La Roche Ltd, Nationwide Children's Hospital, Lysogene, Duke University, Genethon, and StrideBio. Founded in 1980, Sarepta Therapeutics is headquartered in Cambridge, Massachusetts.

Key metrics

Market cap

$2.33B

P/E (TTM)

-36.80

EPS (TTM)

$-0.60

Beta

0.20

Dividend yield

0.00%

Revenue / share

$18.73

50-day avg

$17.84

200-day avg

$19.11

52-week high

$25.32

52-week low

$14.68

CEO

Michael E. Severino

ETFs linked to SRPT

Broad-market and Healthcare sector ETFs an investor holding Sarepta Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how SRPT fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze SRPT in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Sarepta Therapeutics?: Sarepta Therapeutics trades under the ticker SRPT on NASDAQ.
Which exchange is SRPT listed on?: SRPT is listed on NASDAQ.
What sector does Sarepta Therapeutics operate in?: Sarepta Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze SRPT in a portfolio?: PortView shows SRPT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.